We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

An international 'virtual research centre' has been awarded US$300 million to support its efforts to develop an HIV vaccine.

The Center for HIV/AIDS Vaccine Immunology (CHAVI) is a collaboration between four universities from around the world. It is headed by Barton Haynes from Duke University, North Carolina, United States.

The centre is part of the Global HIV Vaccine Enterprise, a public-private initiative to spur HIV vaccine research (see 'Plan to speed up HIV vaccine research unveiled').

CHAVI's research plans include investigating the genetic factors that give some people immunity to the virus. It will also look into why some strains of HIV are more easily transmitted than others.

The seven-year grant was created by the US National Institute of Allergy and Infectious Diseases to fund "a bold new approach" to finding a vaccine.

Link to full Science news story